Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
Submitted by
admin
on August 29, 2018 - 10:38am
Source:
CP Wire
News Tags:
Antibe Therapeutics
ATB-346
NSAIDs
naproxen
Headline:
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
snippet:
ATB-346 is a hydrogen sulfide-releasing derivative of naproxen
H2s has been shown to play important role in the maintenance of gastric mucosal integrity.
Do Not Allow Advertisers to Use My Personal information
